Europe Digital Health Market And Trends 2023

(MENAFN- GlobeNewsWire - Nasdaq)

New York, May 25, 2023 (GLOBE NEWSWIRE) -- announces the release of the report "Europe Digital health market and Trends 2023" -
The report reveals that trends such as telemedicine, connected health, AR/VR, and AI are driving the growth of the digital health market, with a projected double-digit CAGR between 2022 and 2032. Digital health solutions like telemedicine, health & wellness apps, disease management tools, and wearables are gaining popularity among both patients and medical professionals. The UK's National Health Service (NHS) is already utilizing voice-based technology to disseminate health information through websites. While there is increasing demand for digital health technologies, the report notes a decline in total digital health funding between 2021 and 2022 due to investor risk aversion, reduced pandemic-driven growth, inflation, and supply chain disruptions. Concerns over IT/security breaches were also prevalent among two-thirds of surveyed healthcare executives globally in 2022. Surveyed clinicians in Europe faced obstacles such as technology costs, lack of digital health infrastructure, and workforce skills when adopting new digital health technologies in 2022. In Germany, complex healthcare bureaucracy, long approval processes, and lack of market readiness for digital applications were among the top challenges in healthcare system digitalization as of July 2022. Similarly, in Austria, complex IT landscapes and associated interfaces were identified as major obstacles, followed by a lack of knowledge and staff shortages as of October 2022.
While the digital health market is witnessing growth and technological advancements globally, certain digital health tools, such as electronic health records and e-prescriptions, are experiencing slow adoption
The healthcare industry is embracing innovative technologies like AI, telehealth, and telemedicine, which are reshaping the traditional healthcare market. AI, in particular, is expected to empower the healthcare market as stakeholders increasingly turn to its applications. Other digital health tools like telehealth, online appointment booking platforms, wearables, and health apps are also gaining popularity for their convenience and support of advanced techniques like remote patient monitoring. However, the adoption of e-prescriptions and electronic health records remains low across Europe, as stated in the report. In Germany, the investment in digital health records decreased from around three-quarters of healthcare leaders in the previous year to nearly half as of March 2022. Furthermore, Germany is expected to have a significant proportion of paper-based prescriptions by 2023, with digital prescriptions accounting for a smaller share. Over half of surveyed doctors in Germany expressed future intentions to use electronic prescriptions, while many cited technical reasons for not using electronic health records. Lack of patient willingness was also mentioned as a barrier to electronic health record adoption. In contrast, approximately three-quarters of doctors in Switzerland claimed to maintain electronic medical records as of January 2022, according to the report.
For individual Market Report purchases:
1. A“Single User License” means that only one (1) individually named user of an organization shall be entitled to access the report
2. A“Site License” means that up to ten (10) users within a given geographical location (i.e. country) of an organization shall be entitled to access the report
3. A“Global Site License” means that up to ten (10) worldwide users of an organization shall be entitled to access the report
In all cases, the term“organization” refers to the purchaser's specific company only and excludes any third parties, including affiliates.
Read the full report:
About reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.